Your browser doesn't support javascript.
loading
Perspectives and Behaviors of People with Diabetes toward Time in Range and Glucose Control in Diabetes Management: An Online Survey.
De Block, Christophe; Cheng, Alice Y Y; Anil, Gayathri; D'Cruz, John M; Ginovker, Anna.
Afiliação
  • De Block C; Laboratory of Experimental Medicine and Paediatrics, Member of the Infla-Med Center of Excellence, Faculty of Medicine & Health Science, University of Antwerp, Antwerp, Belgium. christophe.deblock@uza.be.
  • Cheng AYY; Department of Endocrinology, Diabetology and Metabolism, Faculty of Medicine and Health Sciences, University Hospital Antwerp, University of Antwerp, Drie Eikenstraat 655, 2650, Edegem, Belgium. christophe.deblock@uza.be.
  • Anil G; Trillium Health Partners and Unity Health, University of Toronto, Toronto, ON, Canada.
  • D'Cruz JM; Global Medical Affairs, Global Business Services, Novo Nordisk Service Centre India Private Limited, Bengaluru, India.
  • Ginovker A; Global Medical Affairs, Global Business Services, Novo Nordisk Service Centre India Private Limited, Bengaluru, India.
Diabetes Ther ; 15(8): 1735-1747, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38861136
ABSTRACT

INTRODUCTION:

This study assessed experiences, attitudes, and behaviors of people with diabetes (PwD) regarding diabetes self-management and glucose control, and their level of awareness, knowledge, and attitudes toward time in range (TIR).

METHODS:

This quantitative survey was conducted using an online questionnaire across seven countries. Respondents were PwD classified into three subgroups type 1 (T1), type 2 insulin (T2 insulin), and type 2 not on insulin (T2 N/insulin).

RESULTS:

Respondents included 621 people in the T1, 780 people in the T2 insulin, and 735 people in the T2 N/insulin subgroups. Awareness of TIR was low, particularly in the T2 N/insulin subgroup (T1 53%, T2 insulin 29%, T2 N/insulin 9%). Despite a lower current use of continuous glucose monitoring (CGM) among the T2 insulin and T2 N/insulin participants (38% and 9%, respectively), versus T1 participants (64%), most (> 70%) were positive toward utilizing new tools and measures to self-manage blood glucose. Recommendations from their healthcare professionals (HCPs) were cited as a strong motivator to try new measures for analyzing glucose levels. The main barriers cited were limited access to CGM and lack of understanding of TIR benefits. Cost was the main reason given by ≥ 40% of respondents for stopping CGM use.

CONCLUSIONS:

There is an unmet need in diabetes management, and TIR and CGM offer a potential solution. PwD are motivated to manage their blood glucose levels and are positive toward utilizing new tools and measures to achieve this goal. HCPs play a pivotal role in informing and guiding PwD on new measures for analyzing glucose.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article